FAVALLI, ANDREA
 Distribuzione geografica
Continente #
EU - Europa 246
NA - Nord America 127
AS - Asia 38
OC - Oceania 3
SA - Sud America 2
Totale 416
Nazione #
US - Stati Uniti d'America 127
IT - Italia 76
DE - Germania 72
IE - Irlanda 65
HK - Hong Kong 20
CN - Cina 16
SE - Svezia 16
FI - Finlandia 4
GB - Regno Unito 4
NL - Olanda 4
AU - Australia 3
BR - Brasile 2
IN - India 2
AT - Austria 1
BE - Belgio 1
FR - Francia 1
RO - Romania 1
UA - Ucraina 1
Totale 416
Città #
Frankfurt am Main 68
Dublin 65
Milan 34
Chandler 28
Ann Arbor 25
New York 22
Hong Kong 20
Shanghai 13
Ashburn 10
Piacenza 4
Brescia 3
Darlington 3
Helsinki 3
The Bronx 3
Atlanta 2
Bergamo 2
Boardman 2
Carate Brianza 2
Fairfield 2
Huizen 2
London 2
Los Angeles 2
Monza 2
Novate Milanese 2
Princeton 2
Pune 2
Ripalta Cremasca 2
Slough 2
Sulmona 2
São Paulo 2
Airuno 1
Bonndorf 1
Brussels 1
Casalecchio di Reno 1
Chicago 1
Cinisello Balsamo 1
Cuasso al Monte 1
Dallas 1
Dalmine 1
Deiva Marina 1
Fremont 1
Groningen 1
Lappeenranta 1
Lavis 1
Lawrence 1
Muggiò 1
Notre Dame 1
Pavia 1
Pioltello 1
Rho 1
Rotterdam 1
Samolaco 1
Trescore Balneario 1
Vienna 1
Washington 1
Wilmington 1
Totale 359
Nome #
Untargeted Mass Spectrometry Approach to Study SARS-CoV-2 Proteins in Human Plasma and Saliva Proteome 98
Integrated longitudinal immunophenotypic, transcriptional and repertoire analyses delineate immune responses in COVID-19 patients 96
Untargeted mass spectrometry approach to study SARS-CoV-2 proteins and characterize human plasma and saliva proteome in COVID-19 patients. 54
Plasma proteome investigation of COVID-19 patients with different outcomes through an untargeted label-free LC-MS/MS approach. 52
Plasma Proteomic Variables Related to COVID-19 Severity: An Untargeted nLC-MS/MS Investigation 41
Immunosuppressant Treatment in Rheumatic Musculoskeletal Diseases Does Not Inhibit Elicitation of Humoral Response to SARS-CoV-2 Infection and Preserves Effector Immune Cell Populations 32
Corrigendum: The Impact of Anti-rheumatic Drugs on the Seroprevalence of Anti-SARS-CoV-2 Antibodies in a Cohort of Patients With Inflammatory Arthritis: The MAINSTREAM Study(Front. Med., (2022), 9, (850858), 10.3389/fmed.2022.850858) 25
Immune response to SARS-CoV-2 natural infection and vaccination in healthy subjects and in immunocompromised patients 17
Plasma proteomic signatures related to COVID-19 disease severity by an untargeted nLC-ESI-MS/MS approach 16
Characterization of SARS-CoV-2 proteins and human proteome in COVID-19 patients’ saliva and plasma: an untargeted mass spectrometry approach 14
Totale 445
Categoria #
all - tutte 2.171
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.171


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202235 0 0 0 0 0 0 0 6 1 0 12 16
2022/2023213 15 37 26 50 12 25 5 11 14 6 9 3
2023/2024197 2 9 13 20 18 62 40 14 11 8 0 0
Totale 445